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Alcoholic liver disease:  
Is acetaminophen safe?
Yes—acetaminophen	is	a	safe	and	
effective	analgesic	that	can	be	
appropriately	used	for	adult	patients	with	
stable	chronic	alcoholic	liver	disease	for	
at	least	a	short	period	of	time	(studies	
have	been	limited	to	a	maximum	of	48–72	
hours),	up	to	the	maximum	recommended	
dosage	of	4	g	daily	(strength	of	
recommendation:	A,	based	on	2	rCts	and	
other	studies).	there	are	little	data	to	guide	
longer-term	use	of	acetaminophen	in	this	
situation.
“Lesser of all evils” 
selecting	an	appropriate	analgesic	for	
patients	with	chronic	alcoholic	liver	
disease	is	complicated.	Narcotics	are	
potentially	addictive,	and	nonsteroidal	
anti-inflammatory	drugs	(NsAIDs)	can	
cause	gastrointestinal	bleeding	and	other	
adverse	events.	Alcoholic	liver	disease	
predisposes	patients	to	these	potential	
drug-related	complications,	so	these	
options	are	not	ideal.	
	 Acetaminophen	is	the	“lesser	of	all	
evils”	in	this	population,	based	on	some	
data	suggesting	it	is	safe	when	used	within	
approved	dosing	parameters.	However,	
these	parameters	vary	significantly.		
	 Although	a	maximum	daily	dose	of	
4	g	is	widely	accepted	as	normal,	the	
American	geriatric	society	recommends	
no	more	than	2	to	3	g	daily	for	older	
patients	with	hepatic	insufficiency	or	a	
history	of	alcohol	abuse.	
	 Moreover,	the	American	liver	
Foundation	issued	a	warning	to	not	
exceed	3	g	daily	for	any	prolonged	period	
of	time	in	response	to	a	2006	clinical	
trial	that	demonstrated	aminotransferase	
increases	in	healthy	volunteers	treated	
with	4	g	of	acetaminophen	daily	for	14	
days.1
	 regardless	of	the	exact	maximum	
dose,	none	are	greater	than	4	g	daily.		
	 Always	judiciously	monitor	dosing	of	
acetaminophen	because	patients	continue	
to	experience	unintentional	overdose	and	
hepatic	failure	caused	by	inadvertent	use	
of	multiple	acetaminophen-containing	
products.2
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z Evidence summary
Acetaminophen, while widely used, is 
hepatotoxic in supra-therapeutic dos-
es.3 Many studies purporting to show 
evidence of hepatic damage from thera-
peutic doses of acetaminophen have also 
been reported. Particularly in the 1970s 
and 1980s, there were a number of case 
reports and small literature reviews 
indicating that hepatic injury among 
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regular users of alcohol (particularly 
chronic alcoholics) who take acetamin-
ophen with therapeutic intent could be 
a “therapeutic misadventure.”4
Recent studies suggest  
short-term safety 
• A systematic review (published in 
2000) identified reports of acetamino-
phen toxicity, poisoning, or adverse 
events for alcohol patients.5 
Researchers found 7 articles classified 
as Class I (studies utilizing randomized 
controlled trials) or Class 2  data (studies 
utilizing prospective, nonrandomized tri-
als), and 20 articles that provided Class 3 
data (retrospective case reviews and case 
reports). 
The studies of Class I and 2 data 
indicated therapeutic dosing of acet-
aminophen is safe for patients with 
liver disease, whereas the Class 3 (low-
er-quality) data suggest acetaminophen 
is toxic for patients with liver disease. 
This review concluded that, based 
on all the methodologically sound stud-
ies available (specifically those using the 
stronger evidence), therapeutic dosing of 
acetaminophen for the alcoholic patient 
is not associated with hepatic injury.
• in a randomized, double-blinded, 
placebo-controlled study, 102 alcoholic 
patients were given 4 g of acetaminophen 
daily for 2 days.6 
Liver enzymes were monitored for 
an additional 2 days. There was no el-
evation in aminotransferases when 
compared with the control group of 
99 patients who received the placebo. 
The mean AST level on day 4 was 38.0 
± 26.7 U/L in the treatment group and 
37.5 ± 27.6 in the placebo group. 
In this brief study, there was no in-
crease in liver toxicity among alcoholic 
patients given the maximal therapeutic 
dose of acetaminophen. 
Recommendations from others
American College of Gastroenterology. The 
American College of Gastroenterology 
states that it’s generally safe to take ac-
etaminophen in the amount specified in 
the package labeling. Furthermore, they 
recommend that patients diagnosed with 
liver conditions consult their physician 
for advice on dosing for acetaminophen 
or any other pain reliever.7 
in Liver and Biliary Disease, the au-
thor concludes that chronic alcoholics 
are at increased risk for hepatotoxic-
ity secondary to acetaminophen even 
at therapeutic doses; therefore, advise 
them to take no more than 2 g daily.8  n
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